CSL had exclusive rights to research two antibodies and we were to get an upfront payment and milestone payments. CSL wasn't mentioned in this years annual report and only scant mention in the 2011 report.
CSL had exclusive rights to research two antibodies and we were...
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1242857 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 1004952 | 2 |
View Market Depth
| Last trade - 10.06am 24/07/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable